The FDA-approved catheters will be used with a mapping system that creates a computer model of the patient's heart. BOSTON SCIENTIFIC Marlborough’s Boston Scientific has received U.S. Food and Drug ...

NATICK, Mass., Boston Scientific Corporation continues to expand its electrophysiology (EP) offerings with U.S. Food and Drug Administration (FDA) approval of its IntellaTip MiFi™ XP catheter and ...

LONDON--(BUSINESS WIRE)--The prevalence of cardiac arrhythmias has increased significantly in recent years, owing to the increased risk of stroke and hospitalizations. This is encouraging various ...

The OCTARAY™ Mapping Catheter with TRUEref™ Technology provides physicians with the precise information needed for catheter ablation procedures that treat cardiac ...

Traditional methods to treat cardiac arrhythmias typically see cardiologists inserting a catheter into the heart to measure electrical impulses and determine where in the tissue the abnormal rhythm is ...

Boston Scientific Corp. (BSX) reported that it has come to terms to buy privately-held Rhythmia Medical Inc., a maker of mapping and navigation systems used in heart surgeries, for up to $265 million ...

Please provide your email address to receive an email when new articles are posted on . Biosense Webster announced the launch of an FDA-cleared catheter with novel technology for mapping cardiac ...

Please provide your email address to receive an email when new articles are posted on . Boston Scientific announced the launch of a monitoring tool to assess effects of radiofrequency energy delivery ...

continues to expand its electrophysiology (EP) offerings with U.S. Food and Drug Administration (FDA) approval of its IntellaTip MiFi™ XP catheter and 510(k) clearance of its Zurpaz™ 8.5F steerable ...